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Abstract 
 The finding of P. falciparum chloroquine resistance (pfcrt) and P. falciparum multidrug resistance 
1(pfmdr1) gene in P. falciparum has become an obstacle in treating malaria. The polymorphism between 
the two genes may result in molecular functions, in cellular components, or in b iological processes. The 
objective of this research is to find similarities between the two genes in 3 components; cellular 
components, molecular functions and b iological processes, based on Gene Ontology. the similarity will be 
counted semantically by path length approach with Wang m ethod. The range of similarity values is 0-1. 
After the similarity value examined; in Molecular Function the similarity is 1 due to the same drug 
transmembrane transporter activity, in Cellular Component is 0,714, the similarity only at the same vacuole 
food cells, and in Biological Processes is 1 due to the same proces in responding to drug. Therefore, this 
research proves both genes have similarities based on gene ontology. 
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1. Introduction 
Malaria is a main health problem in isolated islands, spreaded in tropical and 
subtropical countries in the world [1]-[2]. Malaria is a disease caused by parasites that 
transferred from one carrier to another through the bite of infected Plasmodium anopheles 
mosquitoes. Malaria is still a health major problem in countries in the world, about 214 million 
malaria cases happened all over the world in 2015 [3]. There are four kinds of malaria parasites, 
Plasmodium vivax, Plasmodium ovale, Plasmodium Malariae and Plasmodium Falciparum. 
From which about Plasmodium Falciparum is the most dangerous and lethal [4], [5] . 
There are two kinds of anti malarial that normaly use to cure Falciparum Malaria,  they 
are chloroquine dan sulfadoxine-pyrimethamin. Chloroquine has been decades used as main 
chemotherapy and control [6]. The effort to control malaria has been off-progress, due to the 
finding of gene in Plasmodium falcifparum that resistant to falciparum treatment [3]. The 
emergence of Plasmodium falciparum that resistence to chloroquin has failed the goal of 
controlling Malaria [7]. In research of molecular approach using PCR (polymerase chain 
reaction) technic found the existence of polymorphism on P.  falciparum chloroquine resistance 
transporter (pfcrt) gene and P. falciparum multidrug resistance 1 (pfmdr1) gene that influence 
the chloroquine [8]. Research in molecular is conducted to locate the mutation position in 
various genes related to the resistance [9]. By comparing the sequence of DNA or protein from 
individual that has different evolution. Changes in molecular level can be observed as well as 
resistance. The more differentiation owned by two sequences, the farer the relatives between 
them [10]. 
However, it is not easy to conduct molecular research due to the cost and 
timeconsuming. The presence of knowledge based on ontology can help researcher or public to 
gain prior information of a gene through gen ontology technology. One of the techniques is by 
tracing information in GO (Gene Ontology) to know the characteristic of two genes that related 
to the resistance (GO) is information management of Gene ontology that developed by the Gen 
Ontology Consortium. GO consists of three components, molecular function, biological 
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processes and cellular components [11]. GO is built by using the Web Ontology Language 
(OWL), Gene OWL is one of techniques to create semantic web [12]. Polymorphism that causes 
two genes resistant to antimalarial chloroquine may shows similarities between genes whether 
in biological processes, cellular components or in molecular function. This finding will ease to 
indentify other genes which show indications of resistance. 
To measure the similarities between genes above can be done by  counting the 
similarities between concepts in ontology. There are two kinds of semantic similarity counting in 
Ontology, one based on Information Content [13], [14] and the other based on Path [15]. Prior 
research conducted by [16] to predict the protein functions from human species by using 3 
groups of GO, Molecular function, Cellular component dan Biological processes. [17] Research 
to predict the protein functions involved in mitosis by using annotation data from GO, 2 methods 
used are Bayesian Network dan SVM. [18] Research to predict interaction among proteins in 
yeast by counting semantic similarities based on path WU between two terms in document of 
GO. [19] Analyzed interaction between protein by counting semantic similarities between 
concepts in document of GO by using IC and Path. For Malaria, [20] research to predict 
functions of genes in Plasmodium falcifarum by counting the semantic similarity values based 
on patch to cluster the genes as well as to conduct its enrichment analysis. While researc h on 
antimalarial resistance has been done by [8]. Based on the explanation above on semantic 
similarity counting, many of which to predict function of genes in some species, one of which is 
malaria. Therefore this research is conducted to count the semant ic similarities between 
parasite genes in Plasmodium falciparum that caused resistance to antimalarial choloroquine 
based on documents GO (Gene Ontology) by using Wang methods based on Path. The 
research is hoped to ease identification of other genes that indicated resistance. 
 
 
2. Research Method 
Stages to conduct in this research refer to Figure 1. Stages begin with collecting 
documents, matching gene query to final process of evaluation.  
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Figure 1. Research method 
 
 
Data required in this research are gene ontology documents. Gene Ontology consists  
of 3 components, namely: biological process, molecular function, and cellular component. 
Biological processes show series of processes accomplished by one or more molecular function 
organization. Molecular function shows activity occurs on molecular level such as “catalytic 
activity” or “binding activity”. Cellular component shows component from cell as part of bigger 
object, like an anatomy structure (e.g. crude endoplasm reticulum or core) or group of gene 
products (e.g. ribosome, proteasome or dimmer protein) [11].  
Other data required to this research are database of plasmodium falciparum gene 
species. Apair of Gene 1 and gene 2, Pfcrt and Pfmdr1, by looking up at the database procured 
TELKOMNIKA  ISSN: 1693-6930  
 
Similarities of Antimalarial Resistance Genes in Plasmodium... (Dinar Munggaran Akhmad) 
417 
GO id which represent each gene with its components in gene ontology. Both genes refer to the 
prior research conducted by [8]. 
After having had the GO id in each gene ontology component, the next stage is to form 
Directed Acyclic Graph (DAG) as linier to Wang method [15]. DAG has been formed then the 
next stage is to count the similarity between two genes semantically. Gene ontology arranged 
as directed acyclic (DAG) where each term defines as having associated to one and another in 
the same domain and sometimes to other domains with relation “is -a” and “part-of”. The dot 
lines shows relation “part-of” and the bold line shows relation “is-a”. To measure semantic value 
similarity in GO term, first we have to change the semantic into numeric format; therefore [15] 
define the contribution as S-Value from GO t that related to term A. For so many terms t in 
DAGA (A,TA, EA), S-Value associated to term A, SA(t) define as: 
 
{
  ( )                                                                                   
  ( )     *     ( 
 )|             ( )+       
              (1) 
 
After defining S-Values from all terms in DAGA, then we count semantic value from term 
A in GO, SV(A) as: 
 
  ( )   ∑   ( )              (2) 
 
Let us assume that semantic contribution factor for relation “is -a” and “part-of” is 0,8 and 
0,6 [15] then we use equation 1 and 2 to count S-value in GO term in each DAG. Given 
DAGA=(A,TA, EA) and DAGB= (B,TB, EA) for each term A and B in GO, therefore semantic 
similarity between 2 GO terms, SGO(A, B), defined as Equation 3. 
 
   (   )   
∑ (  ( )    ( ))         
  ( )    ( )
       (3) 
 
Where S(t) is value from S-value from term t GO that associated to term A and SB(t) is 
the value of S-value that associated to term B. Usually a single gene is explained by many GO 
terms. Semantics similarity between a set of GO terms and Go term is GO={ go1, go2,..., gok }, 
Sim (go, GO), defined as maximum semantics similarity among go terms and many more terms  
in a set/series of GO terms with Equation 4. 
 
   (     )   
∑    (        ) ∑    (        )          
   
    (4) 
 
The similarity result will be analyzed and evaluated by reviewing any related literature.  
 
 
3. Results and Analysis 
In this research, there are two genes from Plasmodium falciparum which caused 
resistant to antimalarial chloroquine, they are P. Falciparum Chloroquine Resistant (Pfcrt) and 
P. Falciparum Multidrug 1 (Pfmdr1) which have been part of this research [8]. Those 2 genes 
will be counted semantically their similarity based on ontology and graph method by Wang 
method [15]. Based on the previous explanation on methodology of research1 gene usually 
represented by many terms/GO terms, whether they are in biological process, molecular 
function or in cellular component. Table1 contains GO terms information that explains Pfcrt dan 
Pfmdr1 genes on GO molecular function component. Table 2 contains GO terms information 
that explains Pfcrt dan Pfmdr1 genes on GO Cellular Component and Table 3 on Biological 
Processes component. 
 
 
Table 1. Information on GO Terms Associated to Genes Pfcrt  and Pfmdr1 in Molecular Function 
Pfcrt  
GO:0015238 Drug transmembrane transporter activity 
  
Pfmdr1  
GO:0015238 Drug transmembrane transporter activity 
GO:0042626 ATPase activity, coupled to transmembrane movement of substances 
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Table 2. Information on GO Terms Associated to Genes Pfcrt and Pfmdr1 in Cellular 
Component 
Pfcrt  
GO:0005783 Endoplasmic Reticulum 
GO:0016020 Membrane 
GO:0020020 Food vacuole 
 
 
 
Pfmdr1  
GO:0016021 Integral component of 
membrane 
GO:0020020 Food vacuole 
 
 
Table 3. Information on GO Terms Associated to Genes Pfcrt and Pfmdr1 in Biological 
Processes 
Pfcrt  
GO:0034635 Glutathione transport 
GO:0042493 Response to drug 
  
Pfmdr1  
GO:0042493 Response to drug 
 
 
3.1.    Dag Formation 
3.1.1. DAG GO:0015238 Formation 
Based on Wang method [15], after knowing a pair of genes which will be counted the 
similarity of it, then the next stage is to form Directed Acyclic Graph (DAG) for terms that 
represent genes based on Gene Ontology as shown on Figure 2 below.  
 
 
Drug transmembrane 
transporter activity 
GO:0015238
Drug transporter 
activity
GO:0090484
Transmembrane 
transporter activity
GO:0022857
Transporter 
activity
GO:0005215
Molecular function
GO:0003674
 
 
Figure 2. DAG for GO term drug transmembrane transporter activity:0015238 
 
 
In this paper, one of the GO component will be discussed is Molecular function, due to 
the terms that represent 2 genes resistances to chloroquine, Pfcrt and Pfmdr1 are not so many, 
therefore the form of DAG is more simple. Based Table 1 there will be 2 DAG formations, those 
are GO id GO:0015238 as seen in Figure 2 and GO:0042626 as seen in Figure 3. After DAG 
formed then the next stage is to count S-values in each term in DAG by using Equation 1 and 2. 
Table 4 shows S-values grade for DAG GO:0015238. 
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Table 4. S-values for GO terms in DAG for term Drug Transmembrane Transporter 
Activity:0015238 
GO terms GO:0015238 GO:0090484 GO:0022857 GO:0005215 GO:0003674 
      
S-Value 1.0 0.8 0.8 0.64 0.512 
 
 
3.1.2. DAG GO:0042626 Formation 
Figure 3 shows DAG for GO term ATPase activity, coupled to transmembrane 
movement of substances:0042626. Table 5 shows S-values for DAG GO:0042626. 
 
 
 
 
Figure 3. DAG for GO term ATPase activity, coupled to transmembrane movement of 
substances:0042626 
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Table 5. S-values for GO Terms in DAG for Term ATPase Activity, Coupled to Transmembran 
Movement of Substances:0042626 
GO terms GO:0042626 GO:0016820 GO:0015405 GO:0043492 GO:0022857 
      
S-Value 1.0 0.8 0.8 0.8 0.64 
      
GO terms GO:0016817 GO:0015399 GO:0042623 GO:0005215 GO:000402 
      
S-Value 0.64 0.64 0.64 0.512 0.512 
      
GO terms GO:0017111 GO:0016462 GO:0016818 GO:0016817 GO:0016787 
      
S-Value 0.409 0.327 0.262 0.209 0.168 
      
GO terms GO:0003824 GO:0003674    
      
S-Value 0.134 0.409    
 
 
3.2. Gen Similarity 
After DAG formation and S-value calculation by Equation 1 and 2 have been done, then 
the next stage is to count the semantics similarity values among terms by using equation 3.  The 
result shows in Table 6. 
 
 
Table 6. Similarities between Molecular Function Terms That Annotate Genes Pfcrt and Pfmdr1, 
Respectively 
P
fc
rt
 
pfmdr1 
GO_ID (MF) GO:0015238 GO:0042626 
GO:0015238 1 0.259 
 
 
Based on Table 6 both genes for pfcrt and pfmdr1 have the same characteristics with 
similarity value of 1 by id go GO:0015238. Due to having the same Drug Transmembrane 
Transporter Activity or having resistances to antimalarial drugs surely both genes have the 
same molecule functions. Following by similarity value of 0,259 for id go GO:0015238 and 
GO:0042626, it is happened because GO:0042626 only has part of the same chart as 
GO:015238 those are transmembrane transporter activity and transporter activity. By using 
Equation 4 and 5 acquired similarity result between Pfcrt and Pfmdr1 gene in Molecular 
Function component of 1. With the same stages, the similarity results obtained between Pfcrt 
and Pfmdr1 genes in other GO components, namely Cellular Component and Biological 
Processes, are shown in Table 7 which includes the results of the entire study. 
 
 
Table 7. Similarities between Resistance Genes Pfcrt and Pfmdr1 in 3 GO Components 
Gene Ontology Component 
Gen Resistensi 
Pfcrt         ||     Pfmdr1 
Molecular function 1 
Cellular component 0.714 
Biological processes 1 
 
 
Based on Table 7 using equations 4 and 5 we get the similarity values between the pfcrt 
and pfmdr1 genes in the other 2 GO components: Cellular component and Biological processes. 
Both genes for pfcrt and pfmdr1 have similarity values in the Cellular component of 0.714 
because both genes have similarities in some components such as Food vacuole where every 
parasite such as P.falciparum uses vacuole as its host, Membrane containing all protein and 
protein complex and Integral component of membranes containing complex gene and protein 
products. The similarity value in Biological processes is 1 because both genes have Response 
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to drug which can produce many process changes in cell or organism activity (Plasmodium 
falciparum) by producing drug stimulus.  
Based on the research explanation that relevant to the introduction paragraph, semantic 
similarity measurements predicted more gene functions. However, this study tried to apply 
semantic similarity measurements to measure the similarity between the two genes causing P. 
falciparum resistance to chloroquine. Furthermore, this study can be used to obtain initial 
information about resistance to other P. falciparum genes. The results obtained are only graphic 
images (DAG) and tables. 
Based on the results obtained, this evaluation refers to the literature [21]. There are 
several intrinsic/innate mechanisms: 
a. The parasite is capable of producing enzymes capable of destroying an antimicrobial agent 
before reaching a target or modifying the drug so that it is not recognized by the target. 
b. Parasitic walls become impermeable against antimicrobial agents.  
c. The target position is altered by mutation so that it can no longer related to antimicrobial 
agents. 
d. The parasite performs an efflux pump so that it removes the antimicrobial agent from inside 
the cell before the agent reaches the target. 
e. Specific metabolic pathways in the parasite are genetically altered so that antibiotic genes 
can not produce the expected effect. The response to drugs is slow [22].  
While the mechanism of resistance acquire/acquire one of them can be through mutation. 
Evaluation results as shown in Table 8. 
 
 
Table 8 Evaluation 
Resistance Mechanism 
Gene Ontology Information 
Compatibility GO id Definition 
a.  The parasite is capable of 
producing enzymes 
capable of destroying an 
antimicrobial agent before 
reaching a target or 
modifying the drug so that 
it is not recognized by the 
target. 
  
GO:0042493 
(Response 
to drug) 
 
Any process that results in a change in state or 
activity of a cell or an organism (in terms of 
movement, secretion, enzyme production, gene 
expression, etc.) as a result of a drug stimulus. A 
drug is a substance used in the diagnosis, 
treatment or prevention of a disease. The 
resulting enzyme may affect the response to the 
drug 
*Biological Processes* 
b. The parasitic w all 
becomes impermeable to 
antimicrobial agents. 
  
GO:0016020 
(Membrane)  
A lipid bilayer along w ith all the proteins and 
protein complexes embedded in it an attached to 
it. 
The parasite of P. falciparum certainly has a 
membrane 
*Cellular Component* 
c. The target position is 
altered by mutation so that 
it can no longer bind to 
antimicrobial agents. 
  
GO:0042493 
(Response 
to drug) 
 
Any process that results in a change in state or 
activity of a cell or an organism (in terms of 
movement, secretion, enzyme production, gene 
expression, etc.) as a result of a drug stimulus. A 
drug is a substance used in the diagnosis, 
treatment or prevention of a disease. 
Mutations can alter the position of the target thus 
affecting the response to the drug 
*Biological Processes* 
d. The parasite performs an 
eff lux pump so that it 
removes the antimicrobial 
agent from inside the cell 
before the agent reaches 
the target. 
 
  
GO:0015238 
(Drug 
transmembr
anetransport
er activity) 
 
Enables the directed movement of a drug from 
one side of a membrane to the other. A drug is 
any naturally occurring or synthetic substance, 
other than a nutrient, that, w hen administered or 
applied to an organism, affects the structure or 
functioning of the organism; in particular, any 
such substance used in the diagnosis, prevention, 
or treatment of disease. 
*Molecular Function* 
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Table 8. Continued  
Resistance Mechanism 
Gene OntologyInformation 
Compatibility GO id Definition 
   
 
GO:0016021 
(Integral component 
of membrane)  
 
The component of a membrane 
consisting of the gene products and 
protein complexes having at least 
some part of their peptide sequence 
embedded in the hydrophobic region 
of the membrane. 
*Cellular Component* 
e. Specif ic metabolic 
pathw ays in the parasite 
are genetically altered so 
that antibiotic genes can not 
produce the expected 
effect. 
 
  
GO:0042493 
(Response to drug)  
 
Any process that results in a change 
in state or activity of a cell or an 
organism (in terms of movement, 
secretion, enzyme production, gene 
expression, etc.) as a result of a drug 
stimulus. A drug is a substance used 
in the diagnosis, treatment or 
prevention of a disease. 
Changed paths can also affect the 
response to the drug. 
*Biological Processes* 
f. Mutation 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
  
 
GO:0042493 
(Response to drug) 
 
 
 
 
 
 
 
 
 
GO:0015238 
(ATPase activity, 
coupled to 
transmembrane 
movement of 
substances) 
 
 
 
GO:0020020 (Food 
Vacuole) 
Any process that results in a change 
in state or activity of a cell or an 
organism (in terms of movement, 
secretion, enzyme production, gene 
expression, etc.) as a result of a drug 
stimulus. A drug is a substance used 
in the diagnosis, treatment or 
prevention of a disease. 
The existence of mutations can 
certainly affect/slow  dow n the 
response to the drug. 
*Biological Processes* 
 
Catalysis of the reaction: ATP + 
H2O=ADP + phosphate, to directly 
drive the active transport of a 
substance across a membrane. 
Mutations occur in many ATPase 
codon [8] 
*Molecular Function* 
 
Vacuole w ithin a parasite used for 
digestion of the host cell cytoplasm. 
An example of this component is 
found in the Apicomplexa. 
The parasite P. falciparum lives in the 
vacuole as its host cell. Mutations 
occur in parasitic vacuoles[8]. 
*Cellular Component* 
 
 
4. Conclusion 
Based on the result of similarity calculation using Wang method [15] and evaluation 
result, Gene Ontology can be used to get initial information related to resistance on Plasmodium 
falciparum genes specially. So it can be used also to detect other genes that indicated 
resistance before molecular research. 
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